Lupin s peer Glenmark Pharma had undergone a similar exercise in May 2019, when the latter spun off its API business into a new entity called Glenmark Life Sciences, which made its public market debut in August 2021
Lupin s Canadian arm has received approval from Health Canada to market a generic version of Spiriva (tiotropium bromide inhalation powder) in the country.
Mumbai: Global pharma major Lupin Limited has announced that its Canada subsidiary, Lupin Pharma Canada Ltd., has received approval from Health Canada to market a generic version of Spiriva.